Publicité
Publicité
BOLT
Bolt Biotherapeutics, Inc. Common Stock
5.83
USDSponsorisé
+0.02
+0.34%
09 janv., 15:58 UTC -5
Fermé
Après-marché
5.64
-0.19
-3.26%
BOLT Rapports sur les bénéfices
Ratio de surprise positive
BOLT a dépassé 15 des 20 dernières estimations.
75%
Prochain rapport
Date du prochain rapport
23 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$680.00K
/-$6.22
Variation implicite de Q3 25 (Revenue/ EPS)
-68.65%
/+67.20%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-18.16%
Bolt Biotherapeutics, Inc. Common Stock earnings per share and revenue
On 12 nov. 2025, BOLT reported earnings of -3.72 USD per share (EPS) for Q3 25, beating the estimate of -5.90 USD, resulting in a 36.99% surprise. Revenue reached 2.17 million, compared to an expected 739.50 mille, with a 193.31% difference. The market reacted with a +0.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analystes forecast an EPS of -6.22 USD, with revenue projected to reach 680.00 mille USD, implying an hausse of 67.20% EPS, and baisse of -68.65% in Revenue from the last quarter.
FAQ
What were Bolt Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bolt Biotherapeutics, Inc. Common Stock reported EPS of -$3.72, beating estimates by 36.99%, and revenue of $2.17M, 193.31% above expectations.
How did the market react to Bolt Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.21%, changed from $4.69 before the earnings release to $4.70 the day after.
When is Bolt Biotherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 mars 2026.
What are the forecasts for Bolt Biotherapeutics, Inc. Common Stock's next earnings report?
Based on 7
analystes, Bolt Biotherapeutics, Inc. Common Stock is expected to report EPS of -$6.22 and revenue of $680.00K for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité